SEC Form 4 · accession 0001455244-17-000017
ChronoScale Holdings Corp · CHRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russ Angold
Officer — President, Ekso Labs
Period of report
Aug 11, 2017
Accepted (ET)
Aug 15, 2017 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001549084
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 11, 2017 | S | 100,000 | $1.50 | D | 400,678 | D | |
| Common StockF2 | Aug 14, 2017 | S | 71,746 | $1.59 | D | 328,932 | D | |
| Common StockF3 | Aug 15, 2017 | S | 50,000 | $1.59 | D | 278,932 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.63, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- F2These shares were sold in multiple transactions at prices ranging from $1.55 to $1.74, inclusive.
- F3These shares were sold in multiple transactions at prices ranging from $1.55 to $1.68, inclusive.